Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
03/2003
03/13/2003WO2003020699A2 Tyrosine kinase inhibitors
03/13/2003WO2003020272A1 Compositions and methods for the treatment of cancer
03/13/2003WO2002096359A3 Piperazine pentanamide hiv protease inhibitors
03/13/2003WO2002096317A3 Method for treating glaucoma vi
03/13/2003WO2002088080A3 Dual inhibitors of pde 7 and pde 4
03/13/2003WO2002087513A3 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
03/13/2003WO2002078625A3 Therapeutic combinations for cardiovascular and inflammatory indications
03/13/2003WO2002072543A3 Rxr activating molecules
03/13/2003WO2002068388A3 Acylated piperidine derivatives as melanocortin-4 receptor agonists
03/13/2003WO2002066469A3 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
03/13/2003WO2002055078A3 Use of chromanes for treating parkinson's disease
03/13/2003US20030050331 Cytotoxic agents
03/13/2003US20030050320 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity
03/13/2003US20030050315 An inhibitors of trypsin-like serine protease enzymes, as anticoagulant agents for treatment and prevention of thromboembolic disorders
03/13/2003US20030050311 A novel phenyl oxazoles, thiazoles, oxazolines, oxadiazoles or benzoxazoles for treating neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, amytrophic lateral sclerosis or cerebral trauma
03/13/2003US20030050301 A drug mixture additionally comprising an antihypertensive agent or it's prodrug and a carrier, vehicle or diluent
03/13/2003CA2459918A1 Heteroaryl substituted benzothiazole dioxetanes
03/13/2003CA2459346A1 Benzothiazepine derivatives
03/13/2003CA2458926A1 Methods of treating infection by drug resistant bacteria
03/12/2003EP1291345A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/12/2003EP1289983A2 Heteroarylalkanoic acids as integrin receptor antagonists
03/12/2003EP1289972A1 Serine protease inhibitors
03/12/2003EP1289970A1 3-arylisothiazoles and their use as herbicides
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289960A2 Cycloalkyl alkanoic acids as integrin receptor antagonists
03/12/2003EP1289957A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
03/12/2003EP1289956A1 Chemical compounds
03/12/2003EP1289955A1 Piperidines for use as orexin receptor antagonists
03/12/2003EP1289954A1 Serine protease inhibitors
03/12/2003EP1289953A1 Serine protease inhibitors
03/12/2003EP1289950A1 Serine protease inhibitors
03/12/2003EP1289525A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
03/12/2003EP0874830B1 A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof
03/12/2003CN1402724A Thiazolidinedione derivs. as antidiabetic agents
03/12/2003CN1402721A Benzoimidazole derivs. useful as antiproliferative agents
03/12/2003CN1402720A 2,4-diaminopyrimidine compounds useful as immunosuppressants
03/12/2003CN1402716A Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators
03/12/2003CN1401646A Insecticidal compound and production process thereof
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531609 Process for the preparation of thiazolidinedione derivatives
03/11/2003US6531497 Epothilone derivatives and their synthesis and use
03/11/2003US6531496 Pesticides in crop protection
03/11/2003US6531479 Anti-cancer compounds
03/11/2003US6531470 Oxazolidinone combinatorial libraries, compositions and methods of preparation
03/11/2003US6531469 Substituted 1-(4-piperidyl)-3-(aryl) isothioureas their preparation and their therapeutic application
03/11/2003CA2268129C 1,2,3-thiadiazole derivatives or salts thereof and agrohorticultural disease controller and method for using the same
03/11/2003CA2254117C 2,4-diaminopyrimidine derivatives
03/10/2003CA2401358A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/07/2003WO2002020531A2 Method for producing anellated tetrahydro-[1h]-triazoles
03/07/2003CA2421839A1 Method for producing anellated tetrahydro-[1h]-triazoles
03/06/2003WO2003018578A1 Method for producing beta form of crystalline anhydrous aztreonam
03/06/2003WO2003018576A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity
03/06/2003WO2003018566A1 New piperidinyl derivates as modulators of chemokine receptor activity
03/06/2003WO2003018560A1 N-type calcium channel antagonists for the treatment of pain
03/06/2003WO2003018553A1 Oral antidiabetic agents
03/06/2003WO2003018542A1 Novel norstatin derivative
03/06/2003WO2003018538A1 Novel diarylalkene derivatives and novel diarylalkane derivatives
03/06/2003WO2003018135A1 Method of using 5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase
03/06/2003WO2003018022A1 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
03/06/2003WO2003018021A1 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents
03/06/2003WO2003018019A2 New use of cyclic compounds
03/06/2003WO2003018011A1 5-(substituted)-5-(substitutedsulfonyl or sulfanyl)thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase
03/06/2003WO2003018010A1 Preventive and/or remedial agent for disease attributable to arteriosclerotic activity
03/06/2003WO2003018008A1 Apo ai expression accelerating agent
03/06/2003WO2003018002A2 Cyclopropyl and cyclobutyl epothilone analogs
03/06/2003WO2003017946A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/06/2003WO2002100844A3 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
03/06/2003WO2002099097A8 Novel compounds for chemiluminescense procedures
03/06/2003WO2002083662A3 Azo compounds and process of producing the same and novel intermediate compounds used in the process of producing azo compounds
03/06/2003WO2002072570A3 Non-imidazole compounds as histamine h3 antagonists
03/06/2003WO2002066443A3 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives
03/06/2003WO2002034726A9 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
03/06/2003US20030045728 Indol-3-yl derivatives
03/06/2003US20030045711 Epothilone derivatives and methods for making and using the same
03/06/2003US20030045557 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
03/06/2003US20030045553 Peroxisome proliferator-activated receptor agonists (PPAR) for increasing insulin sensitivity in treatment of diabetes and Syndrome X
03/06/2003US20030045546 Anticancer agents
03/06/2003US20030045519 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion)
03/06/2003US20030044399 Method of treatment
03/06/2003CA2458621A1 Oral antidiabetic agents
03/06/2003CA2458011A1 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
03/06/2003CA2457838A1 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents
03/06/2003CA2457836A1 Preventive and/or remedial agent for disease attributable to arteriosclerotic activity
03/06/2003CA2457532A1 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/06/2003CA2456280A1 Cyclopropyl and cyclobutyl epothilone analogs
03/05/2003EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
03/05/2003EP1288202A1 N-acyltetrahydroisoquinoline derivatives
03/05/2003EP1287018A2 Thrombin inhibitors
03/05/2003EP1286998A1 Oxazolidinone derivatives with antibiotic activity
03/05/2003EP1286992A1 Piperidyindoles as serotonin receptor ligands
03/05/2003EP1286988A2 1-(h-1,2,4-triazol-1-yl)butan-2-ol derivatives
03/05/2003EP1286987A1 Heterocyclic hydrazones for use as anti-cancer agents
03/05/2003EP1286985A1 Substituted pyridine herbicides
03/05/2003EP1286978A1 Cyclohexyl derivatives and their use as therapeutic agents
03/05/2003EP1286975A1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
03/05/2003EP1286972A1 Pyrimidine compounds
03/05/2003EP1286968A2 Substituted iminoazines
03/05/2003EP1286967A1 Cyclohexane derivatives and their use as therapeutic agents
03/05/2003EP1286966A1 4-aminopiperidine derivatives and their use as medicine
1 ... 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 ... 628